SI-BONE Inc. (SIBN)
Company Description
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.
It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures.
The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion.
It markets its products primarily with a direct sales force, as well as through distributors.
The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Country | United States |
IPO Date | Oct 17, 2018 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 349 |
CEO | Laura A. Francis MBA |
Contact Details
Address: 471 El Camino Real Santa Clara, California United States | |
Website | https://si-bone.com |
Stock Details
Ticker Symbol | SIBN |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001459839 |
CUSIP Number | 825704109 |
ISIN Number | US8257041090 |
Employer ID | 26-2216351 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Laura A. Francis MBA | Chief Executive Officer & Director |
Anshul Maheshwari | Chief Financial Officer |
Dr. Scott A. Yerby | Senior Vice President of Engineering & Chief Technology Officer |
Aimee Einstein | Vice President of People & Culture |
Anthony J. Recupero | President of Commercial Operations |
Dr. Daniel Joseph Cher | Senior Vice President of Clinical & Regulatory Affairs |
Dr. W. Carlton Reckling | Chief Medical Officer & Vice President of Medical Affairs |
Jeffrey W. Dunn | Executive Chairman |
Michael A. Pisetsky J.D. | Chief Business & Legal Affairs Officer, Secretary and General Counsel |
Saqib Iqbal | Director of FP&A and Investor Relations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 25, 2025 | S-8 | Filing |
Feb 25, 2025 | 10-K | Annual Report |
Feb 24, 2025 | 8-K | Current Report |
Feb 21, 2025 | 4 | Filing |
Feb 21, 2025 | 4 | Filing |
Feb 21, 2025 | 4 | Filing |
Feb 21, 2025 | 4 | Filing |
Feb 05, 2025 | 4 | Filing |
Feb 05, 2025 | 4 | Filing |
Feb 05, 2025 | 4 | Filing |